دورية أكاديمية

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy

التفاصيل البيبلوغرافية
العنوان: Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy
المؤلفون: Tay, Tricia, Somasundaram, Nagavalli, Lim, Cindy, Khoo, Lay Poh, Goh, Allan Zhi Kai, Lee, Yuh Shan, Liu, Xin, Tao, Miriam, Quek, Richard, Farid, Mohamad, Poon, Eileen, Chan, Jason Y. S., Chang, Esther W. Y., Yang, Valerie S. W., Goh, Yeow Tee, Tan, Daryl, Diong, Colin, Grigoropoulos, Nicholas F., Nagarajan, Chandramouli, Poon, Michelle, de Mel, Sanjay, Jeyasekharan, Anand, Chan, Esther H. L., Lee, Joanne, Chee, Yen Lin, Lim, Soon Thye, Tang, Tiffany
المصدر: Cancer Reports ; volume 5, issue 9 ; ISSN 2573-8348 2573-8348
بيانات النشر: Wiley
سنة النشر: 2022
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
الوصف: Background Contemporary data of peripheral T‐cell lymphoma (PTCL) and natural‐killer/T‐cell lymphoma (NKTL) patients treated with ifosfamide, carboplatin and etoposide (ICE) are limited. Aims We performed a retrospective analysis to estimate outcomes of ICE‐treated PTCL and NKTL patients at three tertiary cancer centres in Singapore. Methods and Results Patients were identified through lymphoma databases from National Cancer Centre Singapore (NCCS), National University Hospital, Singapore (NUHS), and Singapore General Hospital (SGH). Responses and survival outcomes were determined from electronic medical records. A total of 75 patients with a median age of 50 were included. ICE was used as first‐line treatment in 14 patients (19%) and as subsequent lines of treatment in 61 patients (81%). The overall response rates (ORR) for all patients was 63% (40% complete response [CR]). The ORR and CR in the first line were 86% and 64% respectively. At a median follow‐up duration of 71.0 months, the median progression‐free (PFS) and overall survival (OS) for all patients were 4.4 months (95%CI, 2.7–6.0) and 16 months (95%CI, 8.3–45.4) respectively. Conclusion In summary, ICE showed high ORR but poor PFS in relapsed/refractory PTCL and NKTL. ORR of ICE in the first line setting appears better than real‐world CHOP data and warrants further study.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1002/cnr2.1552
الإتاحة: https://doi.org/10.1002/cnr2.1552Test
حقوق: http://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.8FAD7F25
قاعدة البيانات: BASE